NCT03463616

MRI Imaging or CT Abdomen as Standard Work-up Before Treatment Planning for Rectal Cancer?

Completed Last updated 20 April 2021

What this trial tests

trial testing CT abdomen in Rectal Cancer in 320 participants. Completed in 31 December 2020.

Timeline

15 March 2018

Primary endpoint
31 March 2020

31 December 2020

Quick facts

Lead sponsor	Sahlgrenska University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	320
Start date	15 March 2018
Primary completion	31 March 2020
Estimated completion	31 December 2020
Sites	1 location across Sweden

Drugs / interventions tested

• CT abdomen
• MRI abdomen

Conditions studied

• Rectal Cancer — all drugs for Rectal Cancer →
• Liver Metastases — all drugs for Liver Metastases →

Sponsor

Sahlgrenska University Hospital

Who can join

Eligibility, any sex, with Rectal Cancer or Liver Metastases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rectal cancer is a common diagnosis. The prognosis after treatment has improved over the last decades, partly due to neoadjuvant radio(chemo)therapy, but also due to improved surgical technique (TME) and, in certain cases, due to adjuvant therapy after surgery. For some 15-20 years, treatment of metastasis has changed; liver- and lung metastasis in certain situations are surgically removed, or in the liver, treated with ablation (radio-frequency). During the same period the possibilities for chemotherapy of metastatic disease have improved, with new drugs and more drug regimens.

These changes in treatment pathways have required changes in how patients with newly diagnosed rectal cancer are "worked up" pre-treatment. Starting in the early 2000s magnetic resonance imaging of the pelvic area has developed and is today mandatory to be able to adequately stage the tumour and plan for the multi-modal treatment before and after surgery.

In many hospitals the set-up is a combination of computed tomography of the abdomen and chest and to this a MRI of the pelvic organs is added, whereas others have adopted MRI also for the abdominal part, thus having an MRI of the liver for the diagnosis of liver metastasis initially, before surgery. For the chest organs, CT is still normative.

MRI has a higher sensitivity and specificity to detect liver metastasis, compared with CT. In order to plan the liver surgery/ablations, most liver surgeons rely on MRI for detailed information about the position of the metastasis and the relation to large vessels.

The aim of this study is to examine the possible differences in percentage of patients requiring further radiology examinations after basic set-up comparing the routine of initial MRI of abdomen (and pelvic organs) with the routine of initial CT of the abdomen (and MRI of the pelvic organs). Further included is an analysis of the rate of liver metastasis using the two different routines, and finally outcome over 12 months in terms of liver treatment for metastasis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. A Comparison of Liver MRI and Contrast-Enhanced CT as Standard Workup Before Treatment for Rectal Cancer in Usual Care - A Retrospective Study.
   Park J, Block M, Bock D, Kälebo P, et al · · 2022 · PMID 34931986 · DOI 10.2174/1573405617666210712125028